Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

RVPH US Equity

Reviva Pharmaceuticals Holdings, Inc.Health Care · Pharmaceutical Preparations · CIK 1742927 · FY ends Dec 31
$0.50
+0.04 (+8.70%)
USD · as of 2026-08-19 · marketstack
1 8-K filing · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BARCLAYS PLCsec.gov ↗
2026-08-128-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-0313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by INTEGRATED CORE STRATEGIES (US) LLCsec.gov ↗
2026-07-3113G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by UBS Group AGsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-31

Every row is a filed document, checked against its EDGAR index.